Commitments and Contingencies - Additional Information (Details) - Sutro Biopharma Inc - USD ($) $ in Millions		1 Months Ended
	Nov. 21, 2023	Dec. 31, 2022	May 13, 2024
Other Commitments [Line Items]
Upfront consideration		$ 22.5
Upfront consideration in cash		10.0
Upfront consideration in cash after agreement date		$ 5.0
Number of common stock issued (in shares)		167,780
Fair value on date of settlement		$ 8.0
Accrued payment	$ 50.0		$ 25.0
Additional milestone payments in cash	$ 60.0
Common Stock
Other Commitments [Line Items]
Upfront consideration		$ 7.5